BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 23311495)

  • 1. MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma.
    Sarver AL; Thayanithy V; Scott MC; Cleton-Jansen AM; Hogendoorn PC; Modiano JF; Subramanian S
    Orphanet J Rare Dis; 2013 Jan; 8():7. PubMed ID: 23311495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma.
    Thayanithy V; Sarver AL; Kartha RV; Li L; Angstadt AY; Breen M; Steer CJ; Modiano JF; Subramanian S
    Bone; 2012 Jan; 50(1):171-81. PubMed ID: 22037351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasets.
    Hill KE; Kelly AD; Kuijjer ML; Barry W; Rattani A; Garbutt CC; Kissick H; Janeway K; Perez-Atayde A; Goldsmith J; Gebhardt MC; Arredouani MS; Cote G; Hornicek F; Choy E; Duan Z; Quackenbush J; Haibe-Kains B; Spentzos D
    J Hematol Oncol; 2017 May; 10(1):107. PubMed ID: 28506242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Molecular Analysis of Pathologic Fracture-associated Osteosarcoma: MicroRNA profile Is Different and Correlates with Prognosis.
    Lozano Calderón SA; Garbutt C; Kim J; Lietz CE; Chen YL; Bernstein K; Chebib I; Nielsen GP; Deshpande V; Rubio R; Wang YE; Quackenbush J; Delaney T; Raskin K; Schwab J; Cote G; Spentzos D
    Clin Orthop Relat Res; 2019 Sep; 477(9):2114-2126. PubMed ID: 31389890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
    Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
    BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
    Wang Z; Cai H; Lin L; Tang M; Cai H
    Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcoma.
    Maire G; Martin JW; Yoshimoto M; Chilton-MacNeill S; Zielenska M; Squire JA
    Cancer Genet; 2011 Mar; 204(3):138-46. PubMed ID: 21504713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imprinting defects at human 14q32 locus alters gene expression and is associated with the pathobiology of osteosarcoma.
    Shu J; Li L; Sarver AE; Pope EA; Varshney J; Thayanithy V; Spector L; Largaespada DA; Steer CJ; Subramanian S
    Oncotarget; 2016 Apr; 7(16):21298-314. PubMed ID: 26802029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A MicroRNA cluster at 14q32 drives aggressive lung adenocarcinoma.
    Nadal E; Zhong J; Lin J; Reddy RM; Ramnath N; Orringer MB; Chang AC; Beer DG; Chen G
    Clin Cancer Res; 2014 Jun; 20(12):3107-17. PubMed ID: 24833665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variants in the 14q32 miRNA cluster are associated with osteosarcoma risk in the Spanish population.
    Martin-Guerrero I; Bilbao-Aldaiturriaga N; Gutierrez-Camino A; Santos-Zorrozua B; Dolžan V; Patiño-Garcia A; Garcia-Orad A
    Sci Rep; 2018 Oct; 8(1):15414. PubMed ID: 30337581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetically Regulated Chromosome 14q32 miRNA Cluster Induces Metastasis and Predicts Poor Prognosis in Lung Adenocarcinoma Patients.
    González-Vallinas M; Rodríguez-Paredes M; Albrecht M; Sticht C; Stichel D; Gutekunst J; Pitea A; Sass S; Sánchez-Rivera FJ; Lorenzo-Bermejo J; Schmitt J; De La Torre C; Warth A; Theis FJ; Müller NS; Gretz N; Muley T; Meister M; Tschaharganeh DF; Schirmacher P; Matthäus F; Breuhahn K
    Mol Cancer Res; 2018 Mar; 16(3):390-402. PubMed ID: 29330288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of miR-22 acts as an unfavorable prognostic biomarker in osteosarcoma.
    Wang G; Shen N; Cheng L; Lin J; Li K
    Tumour Biol; 2015 Sep; 36(10):7891-5. PubMed ID: 25953260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of miRNA-542-5p in the tumorigenesis of osteosarcoma.
    Zhu T; Fan D; Ye K; Liu B; Cui Z; Liu Z; Tian Y
    FEBS Open Bio; 2020 Apr; 10(4):627-636. PubMed ID: 32105410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-542-5p is a negative prognostic factor and promotes osteosarcoma tumorigenesis by targeting HUWE1.
    Cheng DD; Yu T; Hu T; Yao M; Fan CY; Yang QC
    Oncotarget; 2015 Dec; 6(40):42761-72. PubMed ID: 26498360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased microRNA-452 expression and its prognostic significance in human osteosarcoma.
    Li RZ; Wang LM
    World J Surg Oncol; 2016 May; 14():150. PubMed ID: 27193084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-1908 is a biomarker for poor prognosis in human osteosarcoma.
    Lian D; Wang ZZ; Liu NS
    Eur Rev Med Pharmacol Sci; 2016 Apr; 20(7):1258-62. PubMed ID: 27097944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiRNA profile of osteosarcoma with CD117 and stro-1 expression: miR-1247 functions as an onco-miRNA by targeting MAP3K9.
    Zhao F; Lv J; Gan H; Li Y; Wang R; Zhang H; Wu Q; Chen Y
    Int J Clin Exp Pathol; 2015; 8(2):1451-8. PubMed ID: 25973030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.
    Li X; Yang H; Tian Q; Liu Y; Weng Y
    Neoplasma; 2014; 61(4):453-60. PubMed ID: 24645838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
    Liu W; Zhao ZY; Shi L; Yuan WD
    Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma.
    Fujiwara T; Uotani K; Yoshida A; Morita T; Nezu Y; Kobayashi E; Yoshida A; Uehara T; Omori T; Sugiu K; Komatsubara T; Takeda K; Kunisada T; Kawamura M; Kawai A; Ochiya T; Ozaki T
    Oncotarget; 2017 May; 8(20):33375-33392. PubMed ID: 28380419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.